Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 3c
Get Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q1 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $123.3 million versus the consensus estimate of $163.74 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance
- Artisan Partners Asset Management (APAM) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!